Melanoma

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
CO39262A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION−POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMAMcWhirter, Dr ElaineOpenNCT02908672
ME.13A Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)McWhirter, Dr ElaineOpenNCT02821013
MK-3475-022A Phase I/II Study to Assess the Safety and Efficacy of MK-3475 in Combination with
Trametinib and Dabrafenib in Subjects with Advanced Melanoma
McWhirter, Dr ElaineOpenNCT02130466
Download PDF